ロード中...
A spliced form of CD44 expresses the unique glycan that is recognized by the prostate cancer specific antibody F77
Prostate cancer is the most common cancer occurring in men in the United States. The monoclonal antibody F77 that was originally developed in our laboratory recognizes mainly glycolipids as well as O-linked glycosylation on proteins in prostate cancer cells. We have identified a spliced form of glyc...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5790488/ https://ncbi.nlm.nih.gov/pubmed/29423071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23341 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|